Koninklijke Philips N : Philips Receives US FDA Clearance for Covid-19 Biosensor

By Adriano Marchese

Koninklijke Philips NV said Tuesday that it has received clearance from the U.S. Food and Drug Administration for its wearable biosensor for confirmed and suspected coronavirus patients.

The Dutch technology company said the solution has already received CE mark, and is currently in use with the first install at the OLVG Hospital--a clinical, referral and training hospital in the Netherlands--to help manage the triage and clinical surveillance of Covid-19 patients.

Write to Adriano Marchese at [e-mail]